Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease.

Trépo E, Potthoff A, Pradat P, Bakshi R, Young B, Lagier R, Moreno C, Verset L, Cross R, Degré D, Lemmers A, Gustot T, Berthillon P, Rosenberg W, Trépo C, Sninsky J, Adler M, Wedemeyer H.

J Hepatol. 2011 Jul;55(1):38-44. doi: 10.1016/j.jhep.2010.10.018. Epub 2010 Nov 23.

PMID:
21145859
[PubMed - indexed for MEDLINE]
2.

A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.

Marcolongo M, Young B, Dal Pero F, Fattovich G, Peraro L, Guido M, Sebastiani G, Palù G, Alberti A.

Hepatology. 2009 Oct;50(4):1038-44. doi: 10.1002/hep.23111.

PMID:
19676127
[PubMed - indexed for MEDLINE]
3.

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.

Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C.

Hepatology. 2011 Jul;54(1):60-9. doi: 10.1002/hep.24350.

PMID:
21488075
[PubMed - indexed for MEDLINE]
4.

Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markers.

Fernández-Rodríguez A, Berenguer J, Jiménez-Sousa MA, Guzmán-Fulgencio M, Micheloud D, Miralles P, López JC, Bellón JM, Aldamiz-Echevarria T, García-Broncano P, Carrero A, Alvarez E, Resino S.

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):434-42. doi: 10.1097/QAI.0b013e3182a06eb6.

PMID:
23797694
[PubMed - indexed for MEDLINE]
5.

Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7).

Curto TM, Lagier RJ, Lok AS, Everhart JE, Rowland CM, Sninsky JJ; HALT-C Trial group.

Pharmacogenet Genomics. 2011 Dec;21(12):851-60. doi: 10.1097/FPC.0b013e32834c3e74.

PMID:
21946897
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.

Cholet F, Nousbaum JB, Richecoeur M, Oger E, Cauvin JM, Lagarde N, Robaszkiewicz M, Gouérou H.

Gastroenterol Clin Biol. 2004 Mar;28(3):272-8.

PMID:
15094677
[PubMed - indexed for MEDLINE]
Free Article
7.

A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.

do O NT, Eurich D, Schmitz P, Schmeding M, Heidenhain C, Bahra M, Trautwein C, Neuhaus P, Neumann UP, Wasmuth HE.

Liver Transpl. 2012 Mar;18(3):298-304. doi: 10.1002/lt.22475.

PMID:
22139994
[PubMed - indexed for MEDLINE]
Free Article
8.

Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.

Hissar SS, Kumar M, Tyagi P, Goyal A, Suneetha PV, Agarwal S, Rastogi A, Sakhuja P, Sarin SK.

J Gastroenterol Hepatol. 2009 Apr;24(4):581-7. doi: 10.1111/j.1440-1746.2008.05649.x. Epub 2008 Nov 20.

PMID:
19032460
[PubMed - indexed for MEDLINE]
9.

Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.

Rizzo L, Calvaruso V, Cacopardo B, Alessi N, Attanasio M, Petta S, Fatuzzo F, Montineri A, Mazzola A, L'abbate L, Nunnari G, Bronte F, Di Marco V, Craxì A, Cammà C.

Am J Gastroenterol. 2011 Dec;106(12):2112-20. doi: 10.1038/ajg.2011.341. Epub 2011 Oct 4.

PMID:
21971536
[PubMed - indexed for MEDLINE]
10.

Independent validation of the Enhanced Liver Fibrosis (ELF) score in the ANRS HC EP 23 Fibrostar cohort of patients with chronic hepatitis C.

Guéchot J, Trocmé C, Renversez JC, Sturm N, Zarski JP; ANRS HC EP 23 Fibrostar Study Group.

Clin Chem Lab Med. 2012 Jan 13;50(4):693-9. doi: 10.1515/cclm-2011-0858.

PMID:
22505560
[PubMed - indexed for MEDLINE]
11.

Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M.

J Hepatol. 2011 Jan;54(1):64-71. doi: 10.1016/j.jhep.2010.06.022. Epub 2010 Aug 21.

PMID:
20932598
[PubMed - indexed for MEDLINE]
12.

The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.

Cross TJ, Quaglia A, Hughes S, Joshi D, Harrison PM.

J Viral Hepat. 2009 Jul;16(7):492-9. doi: 10.1111/j.1365-2893.2009.01098.x. Epub 2009 Feb 5.

PMID:
19200134
[PubMed - indexed for MEDLINE]
13.

HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C.

Patel K, Norris S, Lebeck L, Feng A, Clare M, Pianko S, Portmann B, Blatt LM, Koziol J, Conrad A, McHutchison JG.

Hepatology. 2006 Feb;43(2):241-9.

PMID:
16440356
[PubMed - indexed for MEDLINE]
14.

Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients.

Hu SX, Kyulo NL, Xia VW, Hillebrand DJ, Hu KQ.

J Clin Gastroenterol. 2009 Sep;43(8):758-64. doi: 10.1097/MCG.0b013e31818be17c.

PMID:
19238091
[PubMed - indexed for MEDLINE]
15.

Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

Huang H, Shiffman ML, Cheung RC, Layden TJ, Friedman S, Abar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J, Catanese JJ, Leong DU, Ross D, Hu X, Monto A, McAllister LB, Broder S, White T, Sninsky JJ, Wright TL.

Gastroenterology. 2006 May;130(6):1679-87. Epub 2006 Mar 6.

PMID:
16697732
[PubMed - indexed for MEDLINE]
16.

Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C.

Myers RP, Hilsden RJ, Lee SS.

J Viral Hepat. 2001 Jul;8(4):249-55.

PMID:
11454175
[PubMed - indexed for MEDLINE]
17.

Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.

Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Antò M, Capasso R, Zappia V, Ruggiero G.

Hepatology. 2005 May;41(5):995-1003.

PMID:
15834927
[PubMed - indexed for MEDLINE]
18.

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.

Posthouwer D, Mauser-Bunschoten EP, Fischer K, VAN Erpecum KJ, DE Knegt RJ.

J Thromb Haemost. 2007 Jan;5(1):25-30.

PMID:
17239163
[PubMed - indexed for MEDLINE]
19.

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.

Patel K, Thompson AJ, Chuang WL, Lee CM, Peng CY, Shanmuganathan G, Thongsawat S, Tanwandee T, Mahachai V, Pramoolsinsap C, Cho M, Han KH, Shah SR, Foster GR, Clark PJ, Pulkstenis E, Subramanian GM, McHutchison JG.

J Gastroenterol Hepatol. 2011 Jul;26(7):1182-8. doi: 10.1111/j.1440-1746.2011.06722.x.

PMID:
21410752
[PubMed - indexed for MEDLINE]
20.

Fibrosis progression in initially mild chronic hepatitis C.

Boccato S, Pistis R, Noventa F, Guido M, Benvegnù L, Alberti A.

J Viral Hepat. 2006 May;13(5):297-302.

PMID:
16637859
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk